Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnospecIOSP -1.02%76 3-Year EBITDA Growth Rate is -4.20% as of Jun. 2026. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $96.39 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,407 Chemicals companies, Innospec ranks worse than 58.85% on this metric.
During the past 12 months, Innospec's average EBITDA Per Share Growth Rate was -8.20% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -4.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 14.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 2.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Innospec was 37.00% per year. The lowest was -38.70% per year. And the median was 4.90% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Innospec 3-Year EBITDA Growth Rate Related Terms
IOSP vs MTX, NGVT, CC: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Innospec's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innospec 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Innospec's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Innospec's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -4.20% mean?
Innospec (IOSP) has a 3-Year EBITDA Growth Rate of -4.20% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Innospec and its competitors. According to the industry distribution chart, Innospec ranks #828 out of 1407 companies in the Chemicals industry, placing it in the top 58.8%.
Is Innospec's 3-Year EBITDA Growth Rate too high?
Innospec's current 3-Year EBITDA Growth Rate is -4.20%. Based on the distribution chart, Innospec ranks #828 out of 1407 companies in the Chemicals industry, which is below the industry midpoint. Overall, Innospec has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Innospec's 3-Year EBITDA Growth Rate compare to MTX and NGVT?
According to the Chemicals industry distribution chart, Innospec ranks #828 out of 1407 companies for 3-Year EBITDA Growth Rate. This places Innospec in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.90, based on 1,407 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Innospec and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innospec's current 3-Year EBITDA Growth Rate is -4.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Fairly Valued. The stock's GF Value™ is $96.39, compared to a current price of $93.01 — trading 3.5% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -4.20%. Innospec's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Innospec (IOSP), the current 3-Year EBITDA Growth Rate is -4.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innospec (IOSP) Overvalued in 2026?
Based on GuruFocus' analysis, Innospec stock appears to be undervalued.
The current stock price of $93.01 is trading 3.5% below its estimated GF Value™ of $96.39.
GuruFocus considers Innospec to be Fairly Valued.
Key valuation signals for IOSP:
3-Year EBITDA Growth Rate: -4.20%
GF Value™: $96.39 vs. price of $93.01 (3.5% below fair value)
No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score
Get the complete analysis for IOSP
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOSP has been successfully added to your 
